Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Cancer Research

• Publication date

  1987-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 3028614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topoisomerase I interacts with transcribed regions in Drosophila cells.

  1986cited by this paper
• Photosensitive DNA cleavage and phage inactivation by copper(II)-camptothecin.

  1986cited by this paper
• Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

  1985influential reference
• DNA topoisomerases.

  1985cited by this paper
• DNA topoisomerases: enzymes that control DNA conformation.

  1985cited by this paper
• Action of camptothecin and its derivatives on deoxyribonucleic acid.

  1985cited by this paper
• Inhibition of calf thymus type II DNA topoisomerase by poly(ADP‐ribosylation).

  1985cited by this paper
• Inhibition of DNA repair by inhibitors of nuclear ADP-ribosyl transferase.

  1984cited by this paper
• Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.

  1984cited by this paper
• Absence of swiveling at sites of intercalator-induced protein-associated deoxyribonucleic acid strand breaks in mammalian cell nucleoids.

  1984cited by this paper
• Poly(ADP-ribosylation) of DNA topoisomerase I: a nuclear response to DNA-strand interruptions.

  1984cited by this paper
• Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

  1984cited by this paper
• Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

  1984cited by this paper
• Poly(ADP-ribosylation) of a DNA topoisomerase.

  1983cited by this paper
• Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling.

  1983cited by this paper
• DNA topoisomerase I from calf thymus is inhibited in vitro by poly(ADP-ribosylation).

  1983cited by this paper
• Ellipticine-induced protein-associated DNA breaks in isolated L1210 nuclei.

  1982cited by this paper
• DNA topoisomerases.

  1981cited by this paper
• Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.

  1981influential reference
• DNA gyrase and the supercoiling of DNA.

  1980cited by this paper
• Studies on the effects of the antitumor agent camptothecin and derivatives on deoxyribonucleic acid. Mechanism of the scission of deoxyribonucleic acid by photoactivated camptothecin.

  1980cited by this paper
• X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution.

  1979influential reference
• Qualitative and quantitative aspects of intercalator-induced DNA strand breaks.

  1979cited by this paper
• Protein-associated DNA breaks in cells treated with adriamycin or ellipticine.

  1978influential reference
• Supercoils in human DNA.

  1975influential reference
• Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin.

  1971cited by this paper
• Studies on camptothecin. I. Effects of nucleic acid and protein synthesis.

  1971cited by this paper
• Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin.

  1971cited by this paper

• The E2F4 transcriptional repressor is a key mechanistic regulator of colon cancer resistance to irinotecan (CPT-11)

  2025cites this paper
• Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinoma

  2020cites this paper
• Monoterpenoid indole alkaloids from the stems of Kopsia officinalis.

  2020cites this paper
• Synthesis and antitumor activity of biotinylated camptothecin derivatives as potent cytotoxic agents.

  2019cites this paper
• A Novel Camptothecin Derivative 3j Inhibits Nsclc Proliferation Via Induction of Cell Cycle Arrest By Topo I-Mediated DNA Damage.

  2019cites this paper
• REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer.

  2019cites this paper
• The Combination Cyclophosphamide with Radiation Increases Tumour Cure in Ehrlich Ascites Carcinoma Bearing Mice as well as DNA Damage in the Normal Mice Bone Marrow Exposed to Different Doses of Γ-Radiation

  2018cites this paper
• Peptide-Drug Conjugate: A Novel Drug Design Approach.

  2017cites this paper
• What's New in SCLC? A Review

  2017cites this paper
• A novel monoterpenoid indole alkaloid with anticancer activity from Melodinus khasianus.

  2017cites this paper
• Indole Glycosides from Aqueous Fraction of Strychnos nitida

  2016cites this paper
• Synthesis of a peptide-universal nucleotide antigen: towards next-generation antibodies to detect topoisomerase I-DNA covalent complexes.

  2016cites this paper
• Three new monoterpenoid indole alkaloids from Vinca major

  2016cites this paper
• PARP1 Inhibitors: antitumor drug design

  2015cites this paper
• Cytogenetic evidence that DNA topoisomerase II is not involved in radiation induced chromsome-type aberrations.

  2015cites this paper
• Terpenoid indole alkaloids from Mappianthus iodoides Hand.-Mazz.

  2014cites this paper
• Indole alkaloids from cultivated Vinca major

  2014cites this paper
• Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

  2013cites this paper
• PARP and PARP Inhibitor Therapeutics

  2013cites this paper
• The potential of the PARP-1 inhibitor, AGO14699, in human cancers defective in homologous recombination DNA repair

  2012cites this paper
• Melodinines M-U, cytotoxic alkaloids from Melodinus suaveolens.

  2012cites this paper
• New Oral Chemotherapeutic Agents for Lung Cancer

  2012cites this paper
• Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors

  2012cites this paper
• Investigation of the role of poly(ADP-ribose)polymerase inhibition in topoisomerase I poison-induced cytotoxicity

  2012cites this paper
• Poly(ADP-ribose) polymerase and XPF–ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells

  2011cites this paper
• Development of Defined Biological Models for Complex Radiation-Induced DNA Lesions Using Homing Endonucleases and Transposon Technology: Feasibility and Initial Characterization

  2011cites this paper
• THESIS FOR THE DEGREE MASTER OF PHARMACY INVESTIGATION AND OPTIMIZATION OF LIPOSOME FORMULATION FOR USE AS DRUG CARRIER FOR THE ANTICANCER AGENT CAMPTOTHECIN BY ELENAZ NADERKHANI

  2011cites this paper
• Investigation and optimization of liposome formulation for use as drug carrier for the anticancer agent Camptothecin

  2011cites this paper
• Discrimination of the binding mode of DNA ligands by single-photon timing

  2009cites this paper
• Activity of Indenoisoquinolines against African Trypanosomes

  2008cites this paper
• Photoinduced transformation of camptothecin in the presence of iron(III) ions

  2007cites this paper
• Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications.

  2007cites this paper
• Topotecan and Etoposide in the Treatment of Relapsed High-risk Neuroblastoma: Results of a Phase 2 Trial

  2007cites this paper
• Derivative CPT-11 , in the Antitumor Effect of CPT-11 Intracellular Roles of SN-38 , a Metabolite of the Camptothecin Updated Version

  2006cites this paper
• Mechanisms of cellular resistance to camptothecins.

  2006cites this paper
• Topoisomerase I inhibitors: camptothecins and beyond

  2006cites this paper
• PARP Inhibitors and Cancer Therapy

  2006cites this paper
• in Vitro Human Breast Cells Differential Response of Nontumorigenic and Tumorigenic Immunodeficient Mice Treated with 9-Nitrocamptothecin : Regression of Human Breast Carcinoma Tumors in Updated

  2006cites this paper
• INTERACTION OF TOPOISOMERASE I INHIBITORS WITH RADIATION IN CELLS IN VITRO AND IN THE FSAIIC FIBROSARCOMA IN VWO c~~-DIAMMINEDICHLOROPLATINUM(II)-SENSITIVE AND -RESISTANT

  2006cites this paper
• The Role of Checkpoint Kinase 1 in Sensitivity to Topoisomerase I Poisons*

  2005cites this paper
• The Novel Poly(ADP-Ribose) Polymerase Inhibitor, AG14361, Sensitizes Cells to Topoisomerase I Poisons by Increasing the Persistence of DNA Strand Breaks

  2005cites this paper
• Cytotoxic Mechanisms of Topoisomerase 1 Inhibitors

  2005cites this paper
• Heterogeneity in the radiosensitizing effects of the DNA ligand hoechst-33342 in human tumor cell lines.

  2005cites this paper
• Rad9 Protects Cells from Topoisomerase Poison-induced Cell Death*

  2004cites this paper
• Phase II study of topotecan in metastatic hormone-refractory prostate cancer

  2004cites this paper
• A method to determine the incorporation capacity of camptothecin in liposomes

  2004cites this paper
• Emerging role of weekly topotecan in recurrent small cell lung cancer.

  2004cites this paper
• Enteropathogenic Escherichia coli Infection Triggers Host Phospholipid Metabolism Perturbations

  2004cites this paper
• Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent

  2004cites this paper
• Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor.

  2003cites this paper
• Repair of and checkpoint response to topoisomerase I-mediated DNA damage.

  2003cites this paper
• Topoisomerase I Inhibitors: Molecular and Cellular Determinants of Activity

  2003cites this paper
• Treatment with Alstonia scholaris Enhances Radiosensitivity In vitro and In vivo

  2003cites this paper
• Weekly topotecan: an alternative to topotecan's standard daily x 5 schedule?

  2002cites this paper
• Separation methods for camptothecin and related compounds.

  2001cites this paper
• Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro

  2001cites this paper
• The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

  2001cites this paper
• Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines.

  2000cites this paper
• Structure‐Based Analysis of the Effects of Camptothecin on the Activities of Human Topoisomerase I

  2000cites this paper
• Expression of Human Topoisomerase I with a Partial Deletion of the Linker Region Yields Monomeric and Dimeric Enzymes That Respond Differently to Camptothecin*

  2000cites this paper
• Liposomal delivery of camptothecins.

  2000cites this paper
• Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay

  2000cites this paper
• Targeting double-strand breaks to replicating DNA identifies a subpathway of DSB repair that is defective in ataxia-telangiectasia cells.

  1999cites this paper
• Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin.

  1999cites this paper
• Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme.

  1998cites this paper
• Inhibition of pea chloroplast DNA helicase unwinding and ATPase activities by DNA-interacting ligands.

  1998cites this paper
• DNA repair, cell cycle progression and cell death following camptothecin treatment in two murine lymphoma L5178Y sublines

  1998cites this paper
• DNA damage and cytotoxicity induced by beta-lapachone: relation to poly(ADP-ribose) polymerase inhibition.

  1998cites this paper
• Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification.

  1998cites this paper
• Induction of DNA damage, inhibition of DNA synthesis, and suppression of c-myc expression by the topoisomerase I inhibitor, camptothecin, in MCF-7 human breast tumor cells.

  1998cites this paper
• Domains of human topoisomerase I and associated functions.

  1998cites this paper
• Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice.

  1997cites this paper
• Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinoma.

  1997cites this paper
• Damage‐Sensing mechanisms in human cells after ionizing radiation

  1997cites this paper
• Cellular responses to methyl-N-[4-9-acridinylamino)-2-methoxyphenyl] carbamate hydrochloride, an analogue of amsacrine active against non-proliferating cells.

  1997cites this paper
• 2 Recent Advances in the Medicinal Chemistry and Pharmacology of Camptothecin

  1997cites this paper
• Topoisomerase I activity and cellular response to radiation in Chinese hamster cells.

  1996cites this paper
• Phosphorylation of topoisomerase I in L5178Y-S cells is associated with poly(ADP-ribose) metabolism.

  1996cites this paper
• Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence.

  1996cites this paper
• Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors.

  1996cites this paper
• Cellular resistance to topoisomerase poisons.

  1996cites this paper
• Lipid-complexed camptothecin: formulation and initial biodistribution and antitumor activity studies

  1996cites this paper
• Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.

  1996cites this paper
• Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins.

  1996cites this paper
• Camptothecin resistance involving steps subsequent to the formation of protein-linked DNA breaks in human camptothecin-resistant KB cell lines.

  1996cites this paper
• The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation

  1996cites this paper
• Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne.

  1996cites this paper
• Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.

  1996cites this paper
• Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.

  1996cites this paper
• Topoisomerase I activity in squamous cell carcinoma of the head and neck

  1995cites this paper
• Antitrypanosomal activity of camptothecin analogs. Structure-activity correlations.

  1995cites this paper
• Eukaryotic DNA topoisomerases I.

  1995cites this paper
• Sequence-dependent modulation of anticancer drug activities by 7-ethyl-10-hydroxycamptothecin in an HST-1 human squamous carcinoma cell line.

  1995cites this paper
• Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen.

  1995cites this paper
• [Pharmacology of camptothecin and its derivatives].

  1995cites this paper
• Molecular, cellular, and clinical aspects of the pharmacology of 20(S)camptothecin and its derivatives.

  1995cites this paper
• Bcl-2 gene prevents induction of apoptosis in l1210 murine leukemia-cells by sn-38, a metabolite of the camptothecin derivative cpt-11.

  1994cites this paper
• Mechanisms of topoisomerase I inhibition by anticancer drugs.

  1994cites this paper
• Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.

  1994cites this paper
• Studies on intrachromosomal recombination in SP5/V79 Chinese hamster cells upon exposure to different agents related to carcinogenesis.

  1994cites this paper